Diagnosis of the sentinel lymph node in breast cancer: A reproducible molecular method: A multicentric Spanish study

Histopathology

Volumn 58, Issue 6, 2011, Pages 863-869

  Bernet, Laia ^a,b   Cano, Rafael ^a   Martinez, Marcos ^b   Dueñas, Basilio ^b   Matias Guiu, Xavier ^c   Morell, Lluisa ^a   Palacios, Jose ^d   Rezola, Ricardo ^e   Robles Frias, Maria ^d   Ruiz, Irune ^f   Velasco, Ana ^c   Vieites, Begoña ^d   Sevilla, Francisco ^g   Torro, Jose ^g   Medrano, Jose ^g   Ballester, Blai ^a  

^a HOSPITAL LLUÍS ALCANYÍS   (Spain)

^b HOSPITAL DE LA RIBERA   (Spain)

^c Hosp Univ Ciudad de Jaén   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f Hospital Oncológico   (Spain)

^g Hospital de Donosti   (Spain)

Author keywords

Breast cancer sentinel node; Molecular diagnosis; OSNA

Indexed keywords

MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPRODUCIBILITY; SENTINEL LYMPH NODE; SPAIN;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DNA, NEOPLASM; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MONITORING, INTRAOPERATIVE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SPAIN; TIME FACTORS;

EID: 79956065227     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03836.x     Document Type: Article

References (23)

1. Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med. 2003; 349; 546-553.
2. Krishnamurthy S, Meric-Bernstam F, Lucci A et al. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 2009; 115; 1555-1562.
3. Cserni G, Amendoeira I, Apostolikas N et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J. Clin. Pathol. 2004; 57; 695-701.
4. Julian TB, Blumencranz P, Deck K. Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer. J. Clin. Oncol. 2008; 26; 3338-3345.
5. Tsujimoto M, Nakabayashi K, Yoshidome K et al. One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin. Cancer Res. 2007; 13; 4807-4816.
6. Notomi T, Okayama H, Masubuchi H et al. Mediated isothermal amplification of DNA. Nucleic Acids Res. 2000; 28; e63.
7. Sobin LH, Wittekind C. TNM classification of malignant tumors, 6th ed. New York, NY: Wiley-Liss, 2002.
8. Krag D, Weaver D, Ashikaga T et al. The sentinel node in breast cancer. A Multicenter Validation Study. N. Engl. J. Med. 1998; 339; 941-946.
9. Piñero A, Giménez J, Merck B et al. Consensus meeting about sentinel lymph node selective biopsy in breast cancer. Spanish Society of Senology and Breast Pathology. Rev. Esp. Patol. 2007; 40; 91-95.
10. van Deurtzen CH, de Boer M, Monninkhof EM et al. Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J. Natl. Cancer Inst. 2008; 100; 1574-1580.
11. Tan LK, Giri D, Hummer AJ et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J. Clin. Oncol. 2008; 26; 1803-1809.
12. Tamaki Y, Akiyama F, Iwase T et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step-nucleic-acid-amplification assay. Clin. Cancer Res. 2009; 15; 2879-2884.
13. Schem C, Maass N, Bauerschlag DO et al. One-step nucleic acid amplification - a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch. 2009; 454; 203-210.
14. Visser M, Jiwa M, Horstman A et al. Intra-operative rapid diagnostic method based on mRNA CK19 expression for the detection of lymph node metastases in breast cancer. Int. J. Cancer 2008; 122; 2562-2567.
15. Blumencranz P, Whitworth PW, Deck K et al. Sentinel node staging for breast cancer: intra operative molecular pathology overcomes conventional histologic sampling errors. Am. J. Surg. 2007; 194; 426-432.
16. Norton LE, Komenaka IK, Emerson RE et al. Benign glandular inclusions are rare cause of a false positive sentinel node. J. Surg. Oncol. 2007; 95; 593-596.
17. Resetkova E, Hoda SA, Clarke JL et al. Benign heterotopic epithelial inclusions in axillary lymph nodes. Histological and immunohistochemical patterns. Arch. Pathol. Lab. Med. 2003; 127; e25-e27.
18. Yun K, Gunn J, Merrie AEH et al. Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer. Br. J. Cancer 1997; 76; 1112-1113.
19. Bostick PJ, Chatterjee S, Chi DD et al. Limitations of specific reverse-transcriptase polymerase chain reaction targets in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol. 1998; 16; 2632-2640.
20. Zieglschmid V, Hollmann C, Böcher O. Detection of disseminated tumour cells in peripheral blood. Crit. Rev. Clin. Lab. Sci. 2005; 42; 155-196.
21. Ring A, Smith IE, Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol. 2004; 5; 79-88.
22. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasm. Histopathology 2002; 40; 403-439.
23. Ogston KN, Miller ID, Payne S et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 2003; 12; 320-327.